NASDAQ:PACB
Pacific Biosciences of California Stock News
$1.87
-0.0700 (-3.61%)
At Close: May 24, 2024
Why Norwegian Cruise Line Shares Climbed By Around 12%; Here Are 66 Biggest Movers From Yesterday
10:06am, Thursday, 13'th Oct 2022 Benzinga
Gainers
Pintec Technology Holdings Limited (NASDAQ: PT) shares jumped 216.2% to close at $0.9058 on Wednesday.
Agrify Corporation (NASDAQ: AGFY) climbed 88% to close at $ 0.9540 on Wednesday after cl
Moderna, BioNTech And Some Other Big Stocks Moving Higher On Wednesday
02:28pm, Wednesday, 12'th Oct 2022 Benzinga
U.S. stocks traded mostly higher, with the Dow Jones gaining more than 100 points on Wednesday. Here are some big stocks recording gains in today’s session.
FLJ Group Limited (NASDAQ: FLJ) shares j
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
09:09am, Thursday, 29'th Sep 2022 Benzinga
Gainers
PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The tria
PacBio's (PACB) New Method for TR Profiling Now Available
05:08pm, Wednesday, 28'th Sep 2022 Zacks Investment Research
PacBio's (PACB) latest tool is expected to enable scientists to better understand the role of known TRs in human disease, which could also lead to the discovery of novel disease-causing TRs.
Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session
04:40pm, Wednesday, 28'th Sep 2022 Benzinga
Gainers
Prothena Corporation plc (NASDAQ: PRTA) shares climbed 76.4% to $54.54 after Biogen and Eisai Co. Ltd. announced late Tuesday positive results from a late-stage study of their Alzheimer’s
PacBio's (PACB) New Method for TR Profiling Now Available
02:18pm, Wednesday, 28'th Sep 2022
PacBio's (PACB) latest tool is expected to enable scientists to better understand the role of known TRs in human disease, which could also lead to the discovery of novel disease-causing TRs.
3 Reasons to Retain PacBio (PACB) Stock in Your Portfolio
12:02pm, Wednesday, 21'st Sep 2022 Zacks Investment Research
PacBio's (PACB) strength in its Sequel system raises optimism about the stock.
3 Reasons to Retain PacBio (PACB) Stock in Your Portfolio
09:47am, Wednesday, 21'st Sep 2022
PacBio's (PACB) strength in its Sequel system raises optimism about the stock.
U.S. Market Faces Worst Meltdown Since 2020: Here's Why
04:45pm, Wednesday, 14'th Sep 2022 Zacks Investment Research
Major U.S. indices nosedived on Sep 14 following the inflation report for the month of August.
U.S. Market Faces Worst Meltdown Since 2020: Here's Why
02:14pm, Wednesday, 14'th Sep 2022
Major U.S. indices nosedived on Sep 14 following the inflation report for the month of August.
Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday
07:58am, Wednesday, 14'th Sep 2022 Benzinga
Gainers
Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX
Why Amazon, Microsoft, Apple Shares Are Trading Lower, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session
04:32pm, Tuesday, 13'th Sep 2022 Benzinga
Gainers
NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 186% to $47.69 as the stock started trading on a 1-for-30 reverse split basis.
Akero Therapeutics, Inc. (NASDAQ: AKRO) shares climbed 111
FAANG 2.0: Say Hello To MATANA, And Developments In Apple’s New Frontier
12:39pm, Saturday, 10'th Sep 2022 Investing.com
Why PolyPid Dipped Over 73%; Here Are 60 Biggest Movers From Friday
06:55am, Tuesday, 06'th Sep 2022 Benzinga
Gainers
Venus Concept Inc. (NASDAQ: VERO) jumped 54.9% to settle at $0.5419 on Friday. The company, last month, posted downbeat quarterly results.
PaxMedica, Inc. (NASDAQ: PXMD) climbed 47.7% to sett
Why Lululemon Athletica Is Trading Higher By 11%, Here Are 36 Stocks Moving In Friday's Mid-Day Session
04:18pm, Friday, 02'nd Sep 2022 Benzinga
Gainers
NewAge, Inc. (NASDAQ: NBEV) shares climbed 61.3% to $0.1972 on continued volatility after the company recently announced it filed a voluntary petition for relief under chapter 11 of the Unite
